• Microdialysis Systems Enable Researchers to Achieve Greater Sensitivity


Microdialysis Systems Enable Researchers to Achieve Greater Sensitivity

Mar 19 2007

ESA Biosciences, Inc., a subsidiary of Magellan Biosciences, Inc., has introduced two new methods for analysis of microdialysis perfusates that will enable neuroscience researchers to achieve greater sensitivity more rapidly and efficiently.

Using ESA's advanced separation and detection technologies, researchers can now measure norepinephrine (NE), dopamine (DA) and serotonin (5HT) simultaneously with no interference and also measure dopamine and serotonin together in less than four minutes at extremely high sensitivity. Both methods were recently demonstrated at Neuroscience 2006.

ESA's single chromatographic system provides simultaneous quantification of NE, DA and 5HT in a single sample, making more efficient use of each sample and enabling researchers to obtain information about multiple pathways in a single analysis. The unique ESA system also provides a superior method for NE measurement.

According to John Waraska, ESA Director of Marketing, Life Sciences, "Microdialysis users continuously demand greater temporal and spatial resolution in their research. This can be achieved by placing smaller probes into more discrete brain regions, and by increasing the sampling rate. However, the resulting low volume, and dilute samples, can be challenging to analyse, requiring a highly sensitive analytical system. This challenge has now been met by the new ESA method."

The new ESA technology combines high sensitivity and rapid chromatography to reliably measure dopamine and serotonin together in less than four minutes under basal conditions. "The ESA method is virtually measurement at the speed of thought," said Waraska.

"These methods are relevant for behavioural studies a significant advantage for researchers," Waraska added. "They will be of great benefit to any researcher interested in studying the regional interplay of monoamine neurotransmitters during pharmacological manipulation or behaviour." The two applications are achieved using ESA's Model 5300 Coulochem® III detector.

Digital Edition

ILM 49.5 July

July 2024

Chromatography Articles - Understanding PFAS: Analysis and Implications Mass Spectrometry & Spectroscopy Articles - MS detection of Alzheimer’s blood-based biomarkers LIMS - Essent...

View all digital editions


ADLM 2024

Jul 28 2024 San Diego, CA USA

InaLab 2024

Jul 30 2024 Jakarta, Indonesia


Jul 31 2024 Chengdu, China

ACS National Meeting - Fall 2024

Aug 18 2024 Denver, CO, USA


Aug 25 2024 Copenhagen, Denmark

View all events